Chemogenomics and orthology-based design of antibiotic combination therapies

Molecular Systems Biology

Volumn 12, Issue 5, 2016, Pages

  Chandrasekaran, Sriram ^a,b,c   Cokol Cakmak, Melike ^d   Sahin, Nil ^d   Yilancioglu, Kaan ^e   Kazan, Hilal ^f   Collins, James J ^b,c,g,h   Cokol, Murat ^d,i,j  

^a HARVARD UNIVERSITY   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD UNIVERSITY   (United States)

^d SABANCI UNIVERSITY   (Turkey)

^e USKUDAR UNIVERSITY   (Turkey)

^f ANTALYA INTERNATIONAL UNIVERSITY   (Turkey)

^g Massachusetts Institute of Technology Cambridge   (United States)

^h HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

ⁱ TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

chemogenomics; combination therapy; drug resistance; Mycobacterium tuberculosis; Staphylococcus aureus

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; OXACILLIN; RIFAMPICIN; SPECTINOMYCIN; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; CHEMICAL INTERACTION; DRUG ANTAGONISM; DRUG POTENCY; DRUG POTENTIATION; ESCHERICHIA COLI; GENE INACTIVATION; GENE INTERACTION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORTHOLOGY; PHARMACOGENOMICS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; BIOLOGY; CHEMICAL DATABASE; COMBINATION DRUG THERAPY; DRUG EFFECTS; DRUG INTERACTION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM; PROCEDURES;

ANTI-BACTERIAL AGENTS; COMPUTATIONAL BIOLOGY; DATABASES, CHEMICAL; DATABASES, GENETIC; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; GENE REGULATORY NETWORKS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MYCOBACTERIUM TUBERCULOSIS; STAPHYLOCOCCUS AUREUS;

EID: 84971009551     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.15252/msb.20156777     Document Type: Article

References (45)

1. Allison KR, Brynildsen MP, Collins JJ, (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220
2. Bansal M, Yang J, Karan C, Menden MP, Costello JC, Tang H, Xiao G, Li Y, Allen J, Zhong R, Chen B, Kim M, Wang T, Heiser LM, Realubit R, Mattioli M, Alvarez MJ, Shen Y, Gallahan D, Singer D, et al, (2014) A community computational challenge to predict the activity of pairs of compounds. Nat Biotechnol 32: 1213-1222
3. Bhusal Y, Shiohira C, Yamane N, (2005) Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Int J Antimicrob Agents 26: 292-297
4. Bredel M, Jacoby E, (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat Rev Genet 5: 262-275
5. Brown JC, Nelson J, VanderSluis B, Deshpande R, Butts A, Kagan S, Polacheck I, Krysan DJ, Myers CL, Madhani HD, (2014) Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell 159: 1168-1187
6. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJ, Projan S, Thomas CM, Tomasz A, et al, (2011) Tackling antibiotic resistance. Nat Rev Microbiol 9: 894-896
7. Cameron DE, Collins JJ, (2014) Tunable protein degradation in bacteria. Nat Biotechnol 32: 1276-1281
8. Chevereau G, Bollenbach T, (2015) Systematic discovery of drug interaction mechanisms, Vol. 11.
9. Cokol M, Chua HN, Tasan M, Mutlu B, Weinstein ZB, Suzuki Y, Nergiz ME, Costanzo M, Baryshnikova A, Giaever G, Nislow C, Myers CL, Andrews BJ, Boone C, Roth FP, (2011) Systematic exploration of synergistic drug pairs. Mol Syst Biol 7: 544
10. Dancey JE, Chen HX, (2006) Strategies for optimizing combinations of molecularly targeted anticancer agents. Nat Rev Drug Discovery 5: 649-659
11. Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, Takahashi N, Chan CT, Lobritz MA, Braff D, Schwarz EG, Ye JD, Pati M, Vercruysse M, Ralifo PS, Allison KR, Khalil AS, Ting AY, Walker GC, Collins JJ, (2014) Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci USA 111: E2100-E2109
12. Farha MA, Brown ED, (2010) Chemical probes of Escherichia coli uncovered through chemical-chemical interaction profiling with compounds of known biological activity. Chem Biol 17: 852-862
13. Fischbach MA, Walsh CT, (2009) Antibiotics for emerging pathogens. Science 325: 1089-1093
14. Flores AR, Parsons LM, Pavelka MS Jr, (2005) Characterization of novel Mycobacterium tuberculosis and Mycobacterium smegmatis mutants hypersusceptible to beta-lactam antibiotics. J Bacteriol 187: 1892-1900
15. Forrest GN, Tamura K, (2010) Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev 23: 14-34
16. Geva-Zatorsky N, Dekel E, Cohen AA, Danon T, Cohen L, Alon U, (2010) Protein dynamics in drug combinations: a linear superposition of individual-drug responses. Cell 140: 643-651
17. Gill EE, Franco OL, Hancock RE, (2015) Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. Chem Biol Drug Des 85: 56-78
18. Girgis HS, Hottes AK, Tavazoie S, (2009) Genetic architecture of intrinsic antibiotic susceptibility. PLoS ONE 4: e5629
19. Ho CH, Magtanong L, Barker SL, Gresham D, Nishimura S, Natarajan P, Koh JL, Porter J, Gray CA, Andersen RJ, Giaever G, Nislow C, Andrews B, Botstein D, Graham TR, Yoshida M, Boone C, (2009) A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol 27: 369-377
20. Hopkins AL, (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-690
21. Jansen G, Lee AY, Epp E, Fredette A, Surprenant J, Harcus D, Scott M, Tan E, Nishimura T, Whiteway M, Hallett M, Thomas DY, (2009) Chemogenomic profiling predicts antifungal synergies. Mol Syst Biol 5: 338
22. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ, (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810
23. Kohanski MA, DePristo MA, Collins JJ, (2010) Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37: 311-320
24. Lee AY, St Onge RP, Proctor MJ, Wallace IM, Nile AH, Spagnuolo PA, Jitkova Y, Gronda M, Wu Y, Kim MK, Cheung-Ong K, Torres NP, Spear ED, Han MK, Schlecht U, Suresh S, Duby G, Heisler LE, Surendra A, Fung E, et al, (2014) Mapping the cellular response to small molecules using chemogenomic fitness signatures. Science 344: 208-211
25. Lehar J, Stockwell BR, Giaever G, Nislow C, (2008) Combination chemical genetics. Nat Chem Biol 4: 674-681
26. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF, (2011) Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52: 285-292
27. Lobritz MA, Belenky P, Porter CBM, Gutierrez A, Yang JH, Schwarz EG, Dwyer DJ, Khalil AS, Collins JJ, (2015) Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci USA 112: 8173-8180
28. Loewe S, (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3: 285-290
29. Muellner MK, Uras IZ, Gapp BV, Kerzendorfer C, Smida M, Lechtermann H, Craig-Mueller N, Colinge J, Duernberger G, Nijman SM, (2011) A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nat Chem Biol 7: 787-793
30. Nichols RJ, Sen S, Choo YJ, Beltrao P, Zietek M, Chaba R, Lee S, Kazmierczak KM, Lee KJ, Wong A, Shales M, Lovett S, Winkler ME, Krogan NJ, Typas A, Gross CA, (2011) Phenotypic landscape of a bacterial cell. Cell 144: 143-156
31. Ocampo PS, Lázár V, Papp B, Arnoldini M, Zur Wiesch PA, Busa-Fekete R, Fekete G, Pál C, Ackermann M, Bonhoeffer S, (2014) Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrob Agents Chemother 58: 4573-4582
32. Pritchard JR, Bruno PM, Gilbert LA, Capron KL, Lauffenburger DA, Hemann MT, (2013) Defining principles of combination drug mechanisms of action. Proc Natl Acad Sci USA 110: E170-E179
33. Ramon-Garcia S, Ng C, Anderson H, Chao JD, Zheng X, Pfeifer T, Av-Gay Y, Roberge M, Thompson CJ, (2011) Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob Agents Chemother 55: 3861-3869
34. Roemer T, Boone C, (2013) Systems-level antimicrobial drug and drug synergy discovery. Nat Chem Biol 9: 222-231
35. Singh R, Ramachandran V, Shandil R, Sharma S, Khandelwal S, Karmarkar M, Kumar N, Solapure S, Saralaya R, Nanduri R, (2015) In silico-based high-throughput screen for discovery of novel combinations for tuberculosis treatment. Antimicrob Agents Chemother 59: 5664-5674
36. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG, (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 11: 79-109
37. Tamae C, Liu A, Kim K, Sitz D, Hong J, Becket E, Bui A, Solaimani P, Tran KP, Yang H, Miller JH, (2008) Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J Bacteriol 190: 5981-5988
38. Webber MA, Piddock LJ, (2003) The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51: 9-11
39. Whiteside MD, Winsor GL, Laird MR, Brinkman FS, (2013) OrtholugeDB: a bacterial and archaeal orthology resource for improved comparative genomic analysis. Nucleic Acids Res 41: D366-D376
40. Wildenhain J, Spitzer M, Dolma S, Jarvik N, White R, Roy M, Griffiths E, Bellows David S, Wright Gerard D, Tyers M, (2015) Prediction of synergism from chemical-genetic interactions by machine learning. Cell Syst 1: 383-395
41. Wood K, Nishida S, Sontag ED, Cluzel P, (2012) Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc Natl Acad Sci USA 109: 12254-12259
42. Worthington RJ, Melander C, (2013) Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol 31: 177-184
43. Yeh P, Tschumi AI, Kishony R, (2006) Functional classification of drugs by properties of their pairwise interactions. Nat Genet 38: 489-494
44. Yilancioglu K, Weinstein ZB, Meydan C, Akhmetov A, Toprak I, Durmaz A, Iossifov I, Kazan H, Roth FP, Cokol M, (2014) Target-independent prediction of drug synergies using only drug lipophilicity. J Chem Inf Model 54: 2286-2293
45. Zimmermann GR, Lehar J, Keith CT, (2007) Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discovery Today 12: 34-42